The content is available as a PDF (121.3 KB).
. 2017 May 11;66(1):S699. doi: 10.1016/S0168-8278(17)31875-5
The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication
RT Foster
, DR Ure
, DJ Trepanier
, P Gallay
RT Foster
Find articles by RT Foster
DR Ure
Find articles by DR Ure
DJ Trepanier
Find articles by DJ Trepanier
P Gallay
Find articles by P Gallay
Issue date 2017.
Copyright © 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC7172068